GFN•TV will bring the conference's platform for rational and inclusive debate on the future role of safer nicotine products and tobacco harm reduction to an audience all year round. GFN•TV will also be broadcasting live from Warsaw in June. Tune in to hear world-leading experts, tobacco harm reduction advocates and nicotine consumers discuss the latest scientific, regulatory and policy developments. From our unique annual event, to year-round reporting of the issues that matter in tobacco harm reduction, GFN has got it covered.
GFN.TV Interviews #81 | DISTORTED RISK | Cardiometabolic Physician Confronts the War on Safer Nicotine
A massive opportunity to reduce smoking-related death is being squandered. In this episode of GFN Interviews, cardiometabolic physician Dr. Rohan Sequeira examines how public health distorts the public’s understanding of nicotine and risk. With South Asia bearing an enormous tobacco burden, he explains why traditional cessation approaches are failing, why safer nicotine products matter, and how misinformation continues to block harm reduction.
Featuring: DR. ROHAN SEQUEIRA Cardio Metabolic Physician, Non-Invasive Cardiology Medical Director, St. Elizabeth Hospital Mumbai @rohseq
📅 5 Feb 2026
#GFN25 Science Discussion #12 | Vaping as an off-ramp from smoking
Vaping as an Off-Ramp From Smoking. In our next Science Lab session Dr Marewa Glover presents the key findings of the Voices of the 5% Study, a 4-year longitudinal qualitative study of New Zealand adults who used vapes but had no intention of quitting smoking.
📅 2 Feb 2026
GFN News #174 | What the EU Can Learn from Sweden on Nicotine Regulation and Harm Reduction?
In Part 2, Bengt Wiberg explains why EU nicotine policy should be science-based, not political. Drawing on Sweden’s success, he challenges cancer myths, youth claims, and makes the case for smart regulation to reduce smoking and save lives.
📅 30 Jan 2026
GFN News #173 | Are Safer Nicotine Alternatives Being Misrepresented in the EU?
EU nicotine policy is under fire after claims that smoke-free nicotine products are as harmful as cigarettes. In GFN News, Joanna Junak interviews Bengt Wiberg of Stingfree AB on why experts dispute these statements, what science says about nicotine pouches, snus, and vaping, and how the debate could impact tobacco harm reduction and future EU regulation.
📅 28 Jan 2026
GFN News #172 | Is Africa at a Turning Point on Nicotine Policy?
2026 could be a turning point for nicotine policy in Africa. In this episode of GFN News, Joanna Junak speaks with Joseph Magero, consumer advocate and Chairman of the Campaign for Safer Alternatives, about the challenges and opportunities for harm reduction, the impact of restrictive policies, and how countries like South Africa, Kenya, and Nigeria are shaping the future of safer nicotine products.
📅 26 Jan 2026
#GFN25 Science Discussion #11 | Research gaps, priorities and advocate readiness for THR in LMICs
Today's Science Lab session features presentations from Yusuff Adebayo Adebisi & Gabriel Oke. Presentations highlight the need for inovative approaches to tobacco use in LMIC's and identify gaps in THR research in the global and LMIC contexts. Gabriel Oke shares some statistics on tobacco use, health impacts and understanding of SNPs in Africa.
📅 23 Jan 2026
GFN.TV Interviews #80 | POLICY CAPTURE | Bloomberg, the WHO, and Suppression of THR
Public health often warns about tobacco industry interference—but what happens when tobacco control itself is captured by benevolent donors and non-profit organizations? In this GFN interview, economist Roger Bate explains why the World Health Organization’s Framework Convention on Tobacco Control is uniquely vulnerable to outside influence, how Bloomberg-funded NGOs shape policy agendas upstream, and why this system consistently excludes tobacco harm reduction despite strong evidence.
Featuring: DR. ROGER BATE Economist, Health Policy & Medicines Nonresident Scholar, Intl. Center for Law & Economics laweconcenter.org @RogerBate3
📅 21 Jan 2026
#GFN25 Science Discussion #10 | Oral side effects of non-combustible nicotine products
Giusy Rita Maria La Rosa's systematic review and network meta-analysis of 36 randomised contol trials examines the oral health effects of non-combustible nicotine products. Dr Riccardo Polosa takes questions from GFN25 attendee's.
📅 19 Jan 2026
GFN News #171 | Experts Clash Over European Heart Journal Claims
A new European Heart Journal report has reignited the debate over nicotine, heart health, and harm reduction. In this GFN News interview, Will Godfrey of Filter examines the claims that all forms of nicotine pose equal cardiovascular risk and the strong backlash from independent experts.
The discussion explores criticisms of the report’s scientific approach, evidence from population studies, and concerns that its conclusions could influence upcoming EU tobacco, taxation, and health policies. With Europe already facing the world’s highest smoking rates, the video asks whether this narrative could undermine harm reduction efforts and discourage smokers from switching to less harmful alternatives.
📅 16 Jan 2026
#GFN25 Science Discussion #9 | Appraisal of exposure studies on high-powered e-cigarette aerosols
In another Science Lab session Dr Roberto Sussman provides a critiques of e-cigarette aerosol studies and discusses the methodological problems that persist with emission studies, such as overheating coils to produce aldehydes and manufacturing harms.
